Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and remifentanil target-controlled infusion for cesarean section under general anesthesia
ChiCTR-TRC-14004308Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, remifentanil and rocuronium in pregnancy (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Blood pressure, Index of consciousness and 1 more. Started Mar 2013; status: completed.
02
Drugs
propofolremifentanilrocuronium
03
Conditions
pregnancy
Beyond the preview
Go deeper on ChiCTR-TRC-14004308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004308.